Cargando…

White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia

INTRODUCTION: As white matter hyperintensities (WMHs) of the brain are associated with an increased risk of stroke, cognitive decline, and depression, elucidating the associated risk factors is important. In addition to age and hypertension, pre-diabetes and diabetes may play important roles in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosu, Sergio, Lorbeer, Roberto, Hartmann, Felix, Rospleszcz, Susanne, Bamberg, Fabian, Schlett, Christopher L, Galie, Franziska, Selder, Sonja, Auweter, Sigrid, Heier, Margit, Rathmann, Wolfgang, Mueller-Peltzer, Katharina, Ladwig, Karl-Heinz, Peters, Annette, Ertl-Wagner, Birgit B, Stoecklein, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240582/
https://www.ncbi.nlm.nih.gov/pubmed/34183320
http://dx.doi.org/10.1136/bmjdrc-2020-002050
_version_ 1783715240653881344
author Grosu, Sergio
Lorbeer, Roberto
Hartmann, Felix
Rospleszcz, Susanne
Bamberg, Fabian
Schlett, Christopher L
Galie, Franziska
Selder, Sonja
Auweter, Sigrid
Heier, Margit
Rathmann, Wolfgang
Mueller-Peltzer, Katharina
Ladwig, Karl-Heinz
Peters, Annette
Ertl-Wagner, Birgit B
Stoecklein, Sophia
author_facet Grosu, Sergio
Lorbeer, Roberto
Hartmann, Felix
Rospleszcz, Susanne
Bamberg, Fabian
Schlett, Christopher L
Galie, Franziska
Selder, Sonja
Auweter, Sigrid
Heier, Margit
Rathmann, Wolfgang
Mueller-Peltzer, Katharina
Ladwig, Karl-Heinz
Peters, Annette
Ertl-Wagner, Birgit B
Stoecklein, Sophia
author_sort Grosu, Sergio
collection PubMed
description INTRODUCTION: As white matter hyperintensities (WMHs) of the brain are associated with an increased risk of stroke, cognitive decline, and depression, elucidating the associated risk factors is important. In addition to age and hypertension, pre-diabetes and diabetes may play important roles in the development of WMHs. Previous studies have, however, shown conflicting results. We aimed to investigate the effect of diabetes status and quantitative markers of glucose metabolism on WMH volume in a population-based cohort without prior cardiovascular disease. RESEARCH DESIGN AND METHODS: 400 participants underwent 3 T MRI. WMHs were manually segmented on 3D fluid-attenuated inversion recovery images. An oral glucose tolerance test (OGTT) was administered to all participants not previously diagnosed with diabetes to assess 2-hour serum glucose concentrations. Fasting glucose concentrations and glycated hemoglobin (HbA1c) levels were measured. Zero-inflated negative binomial regression analyses of WMH volume and measures of glycemic status were performed while controlling for cardiovascular risk factors and multiple testing. RESULTS: The final study population comprised 388 participants (57% male; age 56.3±9.2 years; n=98 with pre-diabetes, n=51 with diabetes). Higher WMH volume was associated with pre-diabetes (p=0.001) and diabetes (p=0.026) compared with normoglycemic control participants after adjustment for cardiovascular risk factors. 2-hour serum glucose (p<0.001), but not fasting glucose (p=0.389) or HbA1c (p=0.050), showed a significant positive association with WMH volume after adjustment for cardiovascular risk factors. CONCLUSION: Our results indicate that high 2-hour serum glucose concentration in OGTT, but not fasting glucose levels, may be an independent risk factor for the development of WMHs, with the potential to inform intensified prevention strategies in individuals at risk of WMH-associated morbidity.
format Online
Article
Text
id pubmed-8240582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82405822021-07-13 White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia Grosu, Sergio Lorbeer, Roberto Hartmann, Felix Rospleszcz, Susanne Bamberg, Fabian Schlett, Christopher L Galie, Franziska Selder, Sonja Auweter, Sigrid Heier, Margit Rathmann, Wolfgang Mueller-Peltzer, Katharina Ladwig, Karl-Heinz Peters, Annette Ertl-Wagner, Birgit B Stoecklein, Sophia BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: As white matter hyperintensities (WMHs) of the brain are associated with an increased risk of stroke, cognitive decline, and depression, elucidating the associated risk factors is important. In addition to age and hypertension, pre-diabetes and diabetes may play important roles in the development of WMHs. Previous studies have, however, shown conflicting results. We aimed to investigate the effect of diabetes status and quantitative markers of glucose metabolism on WMH volume in a population-based cohort without prior cardiovascular disease. RESEARCH DESIGN AND METHODS: 400 participants underwent 3 T MRI. WMHs were manually segmented on 3D fluid-attenuated inversion recovery images. An oral glucose tolerance test (OGTT) was administered to all participants not previously diagnosed with diabetes to assess 2-hour serum glucose concentrations. Fasting glucose concentrations and glycated hemoglobin (HbA1c) levels were measured. Zero-inflated negative binomial regression analyses of WMH volume and measures of glycemic status were performed while controlling for cardiovascular risk factors and multiple testing. RESULTS: The final study population comprised 388 participants (57% male; age 56.3±9.2 years; n=98 with pre-diabetes, n=51 with diabetes). Higher WMH volume was associated with pre-diabetes (p=0.001) and diabetes (p=0.026) compared with normoglycemic control participants after adjustment for cardiovascular risk factors. 2-hour serum glucose (p<0.001), but not fasting glucose (p=0.389) or HbA1c (p=0.050), showed a significant positive association with WMH volume after adjustment for cardiovascular risk factors. CONCLUSION: Our results indicate that high 2-hour serum glucose concentration in OGTT, but not fasting glucose levels, may be an independent risk factor for the development of WMHs, with the potential to inform intensified prevention strategies in individuals at risk of WMH-associated morbidity. BMJ Publishing Group 2021-06-28 /pmc/articles/PMC8240582/ /pubmed/34183320 http://dx.doi.org/10.1136/bmjdrc-2020-002050 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular and Metabolic Risk
Grosu, Sergio
Lorbeer, Roberto
Hartmann, Felix
Rospleszcz, Susanne
Bamberg, Fabian
Schlett, Christopher L
Galie, Franziska
Selder, Sonja
Auweter, Sigrid
Heier, Margit
Rathmann, Wolfgang
Mueller-Peltzer, Katharina
Ladwig, Karl-Heinz
Peters, Annette
Ertl-Wagner, Birgit B
Stoecklein, Sophia
White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title_full White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title_fullStr White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title_full_unstemmed White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title_short White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
title_sort white matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240582/
https://www.ncbi.nlm.nih.gov/pubmed/34183320
http://dx.doi.org/10.1136/bmjdrc-2020-002050
work_keys_str_mv AT grosusergio whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT lorbeerroberto whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT hartmannfelix whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT rospleszczsusanne whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT bambergfabian whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT schlettchristopherl whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT galiefranziska whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT seldersonja whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT auwetersigrid whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT heiermargit whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT rathmannwolfgang whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT muellerpeltzerkatharina whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT ladwigkarlheinz whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT petersannette whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT ertlwagnerbirgitb whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia
AT stoeckleinsophia whitematterhyperintensityvolumeinprediabetesdiabetesandnormoglycemia